Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed Nov 14, 2019 · 10-Q · 45 days after period end · 0001493152-19-017251
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Net Income | -$561.42K | -$241.74K | -$2.38M | -$4.22M |
| EPS Diluted | -$0.08 | -$0.03 | -$0.61 | -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Sep 30, 2019 · filed Nov 14, 2019 · 45 d after period end
